Edition:
United States

Prima BioMed Ltd (PRR.AX)

PRR.AX on Australia Stock Exchange

0.04AUD
9:31pm EDT
Change (% chg)

$0.00 (+2.44%)
Prev Close
$0.04
Open
$0.04
Day's High
$0.04
Day's Low
$0.04
Volume
1,007,142
Avg. Vol
1,416,260
52-wk High
$0.07
52-wk Low
$0.04

Latest Key Developments (Source: Significant Developments)

Prima Biomed enters agreement with Sydys to advance CVac Program
Thursday, 12 May 2016 03:26am EDT 

Prima BioMed Ltd : PRR enters agreement with Sydys to Advance Cvac Program . In the spin out transaction Prima will receive a 9.9% equity stake in sydys at closing as consideration for the assets being transferred . Prima could receive over A$400 million for achievement of set commercial sales targets, in addition to single digit royalties on sales .  Full Article

Prima BioMed Ltd gains Belgian regulatory approval to commence IIB study of IMP321
Monday, 26 Oct 2015 08:44pm EDT 

Prima BioMed Ltd:Prima Biomed gains Belgian regulatory approval to commence a registration phase IIB study of imp321.Says imp321 phase IIB trial initiation is expected before the end of 2015.  Full Article

Prima BioMed announces investment from Nyenburg
Tuesday, 13 Oct 2015 01:38am EDT 

Prima BioMed Ltd:Has raised about A$1.55 mln via a placement of shares at A$0.05 per share to Nyenburgh Investment Partners (NYIP).The proceeds from the Placement will be used to fund Prima's IMP321 clinical trial program and provide additional working capital.  Full Article

Prima BioMed Ltd announces issue of shares
Tuesday, 23 Jun 2015 02:06am EDT 

Prima BioMed Ltd:Issues 5,000,000 ordinary shares.  Full Article

Prima BioMed Ltd announces issue of shares
Thursday, 11 Jun 2015 03:43am EDT 

Prima BioMed Ltd:Issues 1,266,500 ordinary shares.  Full Article

Prima Biomed Ltd announces ownership interest of JPMorgan Chase & Co and affiliates
Tuesday, 2 Jun 2015 05:23pm EDT 

Prima Biomed Ltd:Says that JPMorgan Chase & Co and its affiliates has an interest in 153,712,260 ordinary shares of the company, representing 8.92 pct. of total voting power.  Full Article

Prima BioMed Ltd announces issue of shares
Thursday, 28 May 2015 03:28am EDT 

Prima BioMed Ltd:Issues 5,000,000 fully paid ordinary shares.  Full Article

Prima BioMed Ltd announces issue of shares
Monday, 25 May 2015 03:19am EDT 

Prima BioMed Ltd:Issues that 185,907,263 ordinary shares.  Full Article

Prima BioMed Ltd to commercialise CVAC'S database management platform with Database Integrations Inc
Sunday, 24 May 2015 07:45pm EDT 

Prima BioMed Ltd:SAYS that it has reached agreement with US-based Database Integrations Inc. (DBI) for two companies to commercialise iCAN, the software platform that powers Prima's CVac cellular therapy, for use in other cellular therapies worldwide.  Full Article

Prima BioMed Ltd announces A$15 million investment from US healthcare investor ridgeback
Wednesday, 13 May 2015 09:26pm EDT 

Prima BioMed Ltd:Enters into agreement with Ridgeback Capital Investments for Ridgeback to invest A$15 million in Prima.Says Ridgeback is a US-based specialist healthcare investor run by Wayne Holman, who is widely regarded as one of world's pre-eminent biotech investors.  Full Article